Osteoarthritis of knee and hip with history of administration of SI-613 / ONO-5704
Conditions
Interventions
None listed
Sponsors
Nishida Yoshihiro
SEIKAGAKU CORPORATION
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Patients with osteoarthritis of the knee or hip who have received one or more JOYCLU intra-articular injection. 2. Patients who fall under any of the following. a. Experienced anaphylaxis (including allergy). Patients who have a history of anaphylactic (including serious allergies) symptoms that are considered to be associated with JOYCLU intra-articular injection after administration of JOYCLU intra-articular injection. Anaphylaxis (including serious allergies) was judged by a physician who performed the medical treatment based on the presence or absence of systemic symptoms such as the patient's skin, digestive organs, respiratory organs, circulatory organs, and neurological symptoms, or the need for urgent treatment and hospitalization. b. No experiences of allergic symptoms. Patients who do not have a history of allergic symptoms that are considered to be related to JOYCLU intra-articular injection after receiving JOYCLU intra-articular injection. 3. Male or female aged 20 years or older at the time of signing the informed consent. 4. Patients who give voluntary written informed consent to participate in the study after receiving and understanding the adequate explanation about the study.
Exclusion criteria
Exclusion criteria: 1. Patients who have a history of anaphylaxis (including serious allergies) within 2 weeks prior to informed consent. 2. Patients who are considered ineligible by the principal investigator or sub-investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| -Basophil Activation Test -An allergen-specific IgE test (ELISA) -An allergen-specific IgE test (Test kit) -Genome-wide association study by genotyping | — |
Contacts
Public ContactYoshihiro Nishida
Nagoya University Hospital
Outcome results
None listed